Авторы

  • Тожиддинов Х.С., Мусашайхова Ш.М.
  • Арипов О.А.
  • Бобоев К.Т.

Ключевые слова:

юрак ишемик касаллиги, ADIPOR2, A219T, адипонектин рецептори, генетик полиморфизм, прогноз, генетик хавф.

Библиографические ссылки

1. Ralapanawa U., Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J Epidemiol Glob Health. 2021;11(2):169–177.

2. Miyazawa K., Ito K. Genetic Analysis for Coronary Artery Disease Toward Diverse Populations. Front Genet. 2021;12:766485.

3. Wang H., Liu Z., Shao J. et al. Pathogenesis of premature coronary artery disease: Focus on risk factors and genetic variants. Genes & Diseases. 2020;9(2):370–380.

4. Yusuf S., Joseph P., Rangarajan S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 countries (PURE): a prospective cohort study. Lancet. 2020; 395(10226):795–808.

5. Gumanova N.G., Gavrilova N.E., Chernushevich O.I. et al. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers. 2017;22(3-4):239–245.

6. Hou H., Ge S., Zhao L. et al. An updated systematic review and meta-analysis of association between adiponectin gene polymorphisms and coronary artery disease. OMICS. 2017;21(6):340–351.

7. Akan G., Görmez S., Atalar F. et al. Association of ADIPOQ gene variants and circulating adiponectin levels with coronary artery disease risk. Cyprus J Med Sci. 2026;11(1):40–47.

8. Medina-Leyte D.J., Zepeda-García O., Domínguez-Pérez M. et al. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):3850.